1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and Cancer of Kidney

1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid has been researched along with Cancer of Kidney in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boerman, OC; Brouwers, AH; Corstens, FH; Frielink, C; Oosterwijk, E; Oyen, WJ; van Eerd, JE	1

Other Studies

1 other study(ies) available for 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and Cancer of Kidney

Article	Year
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:2 Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Humans; Iodine Radioisotopes; Isotope Labeling; Kidney Neoplasms; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes	2004

Article

Year

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:2

Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Humans; Iodine Radioisotopes; Isotope Labeling; Kidney Neoplasms; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes

2004